The Cigna Group (NYSE:CI) Issues FY 2025 Earnings Guidance

The Cigna Group (NYSE:CI - Get Free Report) issued an update on its FY 2025 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 29.500- for the period, compared to the consensus estimate of 33.260. The company issued revenue guidance of -.

The Cigna Group Price Performance

The Cigna Group stock traded down $3.76 during mid-day trading on Tuesday, reaching $316.64. 1,172,135 shares of the company were exchanged, compared to its average volume of 1,566,979. The company has a fifty day simple moving average of $302.25 and a 200-day simple moving average of $314.19. The firm has a market cap of $86.66 billion, a PE ratio of 25.87, a PEG ratio of 0.98 and a beta of 0.53. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83.

The Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period last year, the company posted $6.79 earnings per share. As a group, equities research analysts expect that The Cigna Group will post 29.77 earnings per share for the current fiscal year.

Remove Ads

The Cigna Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th were paid a dividend of $1.51 per share. The ex-dividend date was Wednesday, March 5th. This is a boost from The Cigna Group's previous quarterly dividend of $1.40. This represents a $6.04 annualized dividend and a yield of 1.91%. The Cigna Group's dividend payout ratio is presently 49.35%.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on CI shares. Truist Financial decreased their target price on The Cigna Group from $390.00 to $375.00 and set a "buy" rating on the stock in a research report on Tuesday, February 4th. Piper Sandler reissued an "overweight" rating and set a $348.00 target price (down previously from $394.00) on shares of The Cigna Group in a research report on Monday, February 3rd. Stephens lowered their target price on The Cigna Group from $410.00 to $380.00 and set an "overweight" rating for the company in a report on Friday, January 31st. Raymond James reiterated a "strong-buy" rating and issued a $360.00 price target (down previously from $415.00) on shares of The Cigna Group in a report on Friday, January 31st. Finally, Royal Bank of Canada set a $355.00 target price on The Cigna Group in a research report on Friday, January 31st. Two equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus target price of $373.25.

Insiders Place Their Bets

In other news, insider Nicole S. Jones sold 4,904 shares of the company's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total value of $1,511,020.48. Following the completion of the sale, the insider now directly owns 29,421 shares in the company, valued at $9,065,198.52. This represents a 14.29 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CEO David Cordani sold 26,527 shares of The Cigna Group stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $8,173,499.24. Following the transaction, the chief executive officer now owns 127,767 shares in the company, valued at $39,367,568.04. This trade represents a 17.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 43,751 shares of company stock valued at $13,603,991. Insiders own 0.60% of the company's stock.

Institutional Investors Weigh In On The Cigna Group

A hedge fund recently raised its stake in The Cigna Group stock. Brighton Jones LLC lifted its position in The Cigna Group (NYSE:CI - Free Report) by 9.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,736 shares of the health services provider's stock after purchasing an additional 318 shares during the period. Brighton Jones LLC's holdings in The Cigna Group were worth $1,032,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 86.99% of the stock is owned by institutional investors.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.